{
  "@context": "https://schema.org/",
  "@type": "MedicalCondition",
  "@id": "aku:vascular:genetic:marfan-syndrome",
  "name": "Marfan Syndrome",
  "alternateName": [
    "MFS",
    "Marfan's Syndrome"
  ],
  "description": "Autosomal dominant connective tissue disorder caused by FBN1 gene mutations affecting fibrillin-1. Major vascular manifestations include aortic root dilation, aortic dissection, and mitral valve prolapse. Ghent criteria used for diagnosis.",
  "code": [
    {
      "@type": "MedicalCode",
      "codeValue": "Q87.40",
      "codingSystem": "ICD-10-CM"
    },
    {
      "@type": "MedicalCode",
      "codeValue": "19346006",
      "codingSystem": "SNOMED-CT",
      "name": "Marfan syndrome"
    }
  ],
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/genetic-ctd",
    "type": "definition",
    "subtype": "connective_tissue_disorder",
    "difficulty": "advanced",
    "importance": "foundational",
    "board_yield": "HIGH",
    "aku_id": "MARFAN-001",
    "keywords": [
      "Marfan syndrome",
      "FBN1",
      "fibrillin",
      "aortic aneurysm",
      "connective tissue disorder"
    ],
    "medical_specialty": "vascular_surgery",
    "clinical_context": "genetic_connective_tissue"
  },
  "content": {
    "statement": "aku:vascular:genetic:marfan-syndrome is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Genetic-Ctd that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding aku:vascular:genetic:marfan-syndrome helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of aku:vascular:genetic:marfan-syndrome include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of aku:vascular:genetic:marfan-syndrome."
    }
  },
  "genetics": {
    "inheritance": "Autosomal dominant",
    "gene": "FBN1 (fibrillin-1) on chromosome 15q21.1",
    "mutation_types": "Over 3000 mutations identified",
    "de_novo": "25% of cases are new mutations",
    "prevalence": "1 in 5,000-10,000"
  },
  "pathophysiology": {
    "fibrillin_function": "Major component of extracellular matrix microfibrils",
    "mechanism": [
      "Defective fibrillin-1 reduces microfibril formation",
      "Decreased elastin deposition in aortic wall",
      "Increased TGF-beta signaling (normally sequestered by fibrillin)",
      "Progressive aortic root dilation and dissection risk"
    ]
  },
  "clinical_features": {
    "cardiovascular": {
      "aortic_root_dilation": "Most important - occurs in 80%+",
      "aortic_dissection": "Type A dissection, major cause of mortality",
      "aortic_regurgitation": "Secondary to root dilation",
      "mitral_valve_prolapse": "Common, may cause regurgitation",
      "arrhythmias": "MVP-associated, may cause sudden death"
    },
    "skeletal": [
      "Tall stature with long limbs (dolichostenomelia)",
      "Arm span > height",
      "Arachnodactyly (spider fingers)",
      "Positive Walker-Murdoch and Steinberg signs",
      "Pectus excavatum or carinatum",
      "Scoliosis",
      "Hindfoot deformity"
    ],
    "ocular": {
      "ectopia_lentis": "Lens dislocation, typically superotemporal",
      "myopia": "Severe early-onset",
      "retinal_detachment": "Increased risk"
    },
    "pulmonary": [
      "Spontaneous pneumothorax",
      "Apical blebs"
    ],
    "dural": "Dural ectasia (lumbosacral)"
  },
  "diagnosis": {
    "ghent_nosology_2010": {
      "aortic_root_z_score": "\u22652 OR aortic dissection",
      "ectopia_lentis": "Present",
      "fbn1_mutation": "Known to cause Marfan",
      "systemic_score": "\u22657 points",
      "combinations": [
        "Ao + EL = Marfan",
        "Ao + FBN1 = Marfan",
        "EL + FBN1 = Marfan",
        "Ao + systemic \u22657 = Marfan (if no EL)"
      ]
    },
    "imaging": {
      "echocardiography": "Measure aortic root at sinuses of Valsalva",
      "z_score": "Normalize to body surface area",
      "ct_mri": "Complete aortic imaging for dissection screening"
    }
  },
  "management": {
    "medical": {
      "beta_blockers": "First-line to reduce aortic wall stress",
      "arbs": "Losartan (reduces TGF-beta signaling)",
      "blood_pressure_control": "Target <120/80"
    },
    "surgical": {
      "prophylactic_aortic_root_replacement": {
        "threshold": "5.0 cm (or 4.5 cm with family history of dissection)",
        "procedure": "Valve-sparing root replacement (David) or Bentall"
      },
      "emergent": "Immediate repair for dissection"
    },
    "lifestyle": {
      "activity_restriction": "Avoid contact sports, isometric exercise",
      "competitive_sports": "Generally contraindicated"
    },
    "pregnancy": {
      "high_risk": "Increased dissection risk",
      "threshold": "Avoid if aortic root >4.0-4.5 cm",
      "management": "Close monitoring, beta-blockade, consider C-section"
    }
  },
  "clinical_pearls": [
    "Ectopia lentis in Marfan = UPWARD (vs Homocystinuria = DOWNWARD)",
    "Aortic root replacement threshold is 5.0 cm (lower than degenerative aneurysm)",
    "Beta-blockers AND losartan used together in many centers",
    "Annual echocardiography required for surveillance"
  ],
  "semantic_relations": {
    "broader": [
      "aku:vascular:genetic-ctd:overview"
    ],
    "narrower": [],
    "related": [
      "aku:vascular:aaa:ascending-aortic-aneurysm",
      "aku:vascular:dissection:type-a",
      "aku:vascular:genetic:loeys-dietz"
    ]
  },
  "learning_objectives": [
    "Apply the Ghent criteria for Marfan syndrome diagnosis",
    "Describe the pathophysiology of aortic disease in Marfan syndrome",
    "Outline surgical thresholds and medical management"
  ],
  "relationships": {
    "prerequisites": [],
    "enables": [
      {
        "id": "aku:vascular:genetic:marfan-003-root-replacement",
        "title": "Aortic Root Replacement in Marfan",
        "strength": 1.0,
        "reason": "Foundational knowledge for surgical management"
      },
      {
        "id": "aku:vascular:genetic:marfan-005-beta-blocker",
        "title": "Beta-Blocker Prophylaxis",
        "strength": 1.0,
        "reason": "Foundational knowledge for medical management"
      }
    ],
    "related": [
      {
        "id": "aku:vascular:genetic:loeys-dietz-syndrome",
        "type": "differential_diagnosis",
        "relationship": "Similar but more aggressive connective tissue disorder"
      },
      {
        "id": "aku:vascular:genetic:vascular-ehlers-danlos",
        "type": "differential_diagnosis",
        "relationship": "Different mechanism but similar vascular complications"
      }
    ]
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). aku:vascular:genetic:marfan-syndrome. Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  },
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-06T02:30:00.000Z",
    "updated": "2026-01-06T02:30:00.000Z",
    "contributors": [
      "copilot"
    ],
    "status": "enhanced",
    "confidence": 0.95,
    "modified": "2026-01-09T11:29:00.000Z"
  }
}